BioCryst Pharmaceuticals Inc (BCRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BCRX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 307 institutions reported holding BCRX, with 261.4 million shares worth $2.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 24,624,607 | $246M | INCREASED |
| BlackRock | 23,893,036 | $239M | INCREASED |
| RA Capital Management | 15,827,186 | $158M | UNCHANGED |
| State Street | 15,191,098 | $152M | INCREASED |
| Deerfield Management Company | 15,096,403 | $151M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jon P Stonehouse (Director) | AWARD | 644 | $6K | 2026-08-31 |
| Jill C. Milne (Director) | AWARD | 1,288 | $12K | 2026-08-31 |
| Vincent Milano (Director) | AWARD | 1,159 | $11K | 2026-08-31 |
| Amy E Mckee (Director) | AWARD | 644 | $6K | 2026-08-31 |
| Steven Frank (Director) | AWARD | 1,288 | $12K | 2026-08-31 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-07-10 |
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-07-09 |
Full institutional holdings, insider history, and congressional trades for BioCryst Pharmaceuticals Inc on SentiSense.